{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:41:56Z","timestamp":1787240516445,"version":"build-2736575974"},"reference-count":284,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006401","name":"Fondation Charcot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cellimm.2020.104236","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T21:09:48Z","timestamp":1602536988000},"page":"104236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?"],"prefix":"10.1016","volume":"358","author":[{"given":"Ibo","family":"Janssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-901X","authenticated-orcid":false,"given":"Nathalie","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.seminoncol.2012.10.001","article-title":"Immune tolerance and transplantation","volume":"39","author":"Alpdogan","year":"2012","journal-title":"Semin. Oncol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10875-008-9254-8","article-title":"Peripherally induced Treg: mode, stability, and role in specific tolerance","volume":"28","author":"Apostolou","year":"2008","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0015","first-page":"903","article-title":"Infectious immunological tolerance","volume":"21","author":"Gershon","year":"1971","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4049\/jimmunol.108.3.586","article-title":"Suppressor T cells","volume":"108","author":"Gershon","year":"1972","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","article-title":"Regulatory T cell plasticity and stability and autoimmune diseases","volume":"58","author":"Qiu","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029041","article-title":"Regulatory T cells: from discovery to autoimmunity","volume":"8","author":"Kitz","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0045","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104236_b0055","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b0065","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0070","first-page":"277","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20032158","article-title":"Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II","volume":"199","author":"Kriegel","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2020.104236_b0095","doi-asserted-by":"crossref","first-page":"3476023","DOI":"10.1155\/2016\/3476023","article-title":"Genetic factors of autoimmune diseases","volume":"2016","author":"Ceccarelli","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cellimm.2020.104236_b0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coi.2017.08.013","article-title":"Immunomodulation in multiple sclerosis: promises and pitfalls","volume":"49","author":"Dendrou","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2174\/157015911796557939","article-title":"Toxicities of immunosuppressive treatment of autoimmune neurologic diseases","volume":"9","author":"Lallana","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2008.02900.x","article-title":"Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?","volume":"125","author":"Vandenbark","year":"2008","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0115","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12415","article-title":"Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells","volume":"178","author":"Tanaka","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0125","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/eji.200940030","article-title":"Regulatory T cells for the prevention of graft-versus-host disease: professionals defeat amateurs","volume":"39","author":"Edinger","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0130","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4049\/jimmunol.176.2.1266","article-title":"Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation\/differentiation of pathogenic T cells","volume":"176","author":"Trenado","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0135","doi-asserted-by":"crossref","first-page":"e90387","DOI":"10.1371\/journal.pone.0090387","article-title":"Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rgammanull mice","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS ONE"},{"issue":"83","key":"10.1016\/j.cellimm.2020.104236_b0140","doi-asserted-by":"crossref","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"43","key":"10.1016\/j.cellimm.2020.104236_b0145","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0155","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nri2416","article-title":"Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice","volume":"8","author":"Singer","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2015.00395","article-title":"Regulatory T-cell development in the human thymus","volume":"6","author":"Caramalho","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0165","doi-asserted-by":"crossref","unstructured":"Cadiele Oliana Reichert, J.d.C., D\u00e9bora Levy, Luciana Morganti Ferreira Maselli, S\u00e9rgio Paulo Bydlowski and Celso Spada, Regulatory T Lymphocytes (Treg): Modulation and Clinical Application, in Lymphocyte Updates - Cancer, Autoimmunity and Infection, G. Isvoranu, Editor. 2017, IntechOpen: https:\/\/www.intechopen.com\/books\/lymphocyte-updates-cancer-autoimmunity-and-infection\/regulatory-t-lymphocytes-treg-modulation-and-clinical-application.","DOI":"10.5772\/intechopen.69152"},{"issue":"5160","key":"10.1016\/j.cellimm.2020.104236_b0170","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1126\/science.8171333","article-title":"Selecting the T cell receptor repertoire","volume":"264","author":"Bevan","year":"1994","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20110308","article-title":"T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse","volume":"208","author":"Moran","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0180","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.1700156","article-title":"Cutting edge: low-affinity TCRs support regulatory T cell function in autoimmunity","volume":"200","author":"Sprouse","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0185","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory T cells expressing De Novo autoreactive T-cell receptors in Type 1 diabetes","volume":"8","author":"Yeh","year":"2017","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.cellimm.2020.104236_b0190","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2011-09-377051","article-title":"TCR affinity and specificity requirements for human regulatory T-cell function","volume":"119","author":"Plesa","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0195","doi-asserted-by":"crossref","first-page":"p. Fso186","DOI":"10.4155\/fsoa-2016-0095","article-title":"The development of T cells from stem cells in mice and humans","volume":"3","author":"Famili","year":"2017","journal-title":"Future Sci. OA"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ni1318","article-title":"An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires","volume":"7","author":"Hsieh","year":"2006","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0205","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.immuni.2007.11.022","article-title":"Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire","volume":"28","author":"Burchill","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0215","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ni.1607","article-title":"A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells","volume":"9","author":"Liu","year":"2008","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0220","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood-2006-11-055756","article-title":"Nonredundant roles for Stat5a\/b in directly regulating Foxp3","volume":"109","author":"Yao","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ni.2868","article-title":"Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells","volume":"15","author":"Arvey","year":"2014","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cell.2012.06.053","article-title":"Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification","volume":"151","author":"Samstein","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0245","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","article-title":"Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation","volume":"182","author":"Lal","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0255","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol."},{"issue":"Suppl","key":"10.1016\/j.cellimm.2020.104236_b0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2005.04.008","article-title":"IPEX and FOXP3: clinical and research perspectives","volume":"25","author":"Wildin","year":"2005","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0275","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0285","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2018.12.016","article-title":"A Mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells","volume":"50","author":"Van Gool","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0295","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ni.2402","article-title":"Transcription factor Foxp3 and its protein partners form a complex regulatory network","volume":"13","author":"Rudra","year":"2012","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.3053","article-title":"Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance","volume":"16","author":"Yu","year":"2015","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0305","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4049\/jimmunol.1102288","article-title":"Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression","volume":"188","author":"Hansmann","year":"2012","journal-title":"J. Immunol."},{"issue":"7129","key":"10.1016\/j.cellimm.2020.104236_b0310","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104236_b0315","doi-asserted-by":"crossref","unstructured":"Gambineri, E., et al., Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, Front. Immunol. 9 (2411) (2018).","DOI":"10.3389\/fimmu.2018.02411"},{"key":"10.1016\/j.cellimm.2020.104236_b0320","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0325","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin. Immunol."},{"issue":"6204","key":"10.1016\/j.cellimm.2020.104236_b0330","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0335","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/eji.201040909","article-title":"Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome","volume":"41","author":"Passerini","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0340","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4049\/jimmunol.1302378","article-title":"Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice","volume":"192","author":"Kim","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0345","doi-asserted-by":"crossref","first-page":"2609737","DOI":"10.1155\/2019\/2609737","article-title":"The critical role of Bach2 in shaping the balance between CD4<sup>+<\/sup> T cell subsets in immune-mediated diseases","volume":"2019","author":"Yang","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"7\u20138","key":"10.1016\/j.cellimm.2020.104236_b0350","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.molimm.2010.02.001","article-title":"A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells","volume":"47","author":"Getnet","year":"2010","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0355","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/eji.201847935","article-title":"Helios(+) and Helios(-) Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires","volume":"49","author":"Thornton","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.cellimm.2020.104236_b0360","doi-asserted-by":"crossref","first-page":"S338","DOI":"10.21037\/tcr.2016.07.37","article-title":"Helios-controller of Treg stability and function","volume":"5","author":"Chougnet","year":"2016","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0365","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0370","doi-asserted-by":"crossref","first-page":"e1420","DOI":"10.1038\/cddis.2014.377","article-title":"Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand","volume":"5","author":"Nazzal","year":"2014","journal-title":"Cell Death Dis."},{"issue":"7054","key":"10.1016\/j.cellimm.2020.104236_b0375","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","article-title":"Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436","author":"Watanabe","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0380","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.4049\/jimmunol.176.6.3593","article-title":"Molecular mechanisms underlying FOXP3 induction in human T cells","volume":"176","author":"Mantel","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0385","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"5609","key":"10.1016\/j.cellimm.2020.104236_b0390","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2020.104236_b0395","doi-asserted-by":"crossref","first-page":"308265","DOI":"10.1100\/2012\/308265","article-title":"CD8+ T cells: GITR matters","volume":"2012","author":"Ronchetti","year":"2012","journal-title":"Scientific World J."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0405","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0410","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6029","key":"10.1016\/j.cellimm.2020.104236_b0415","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0420","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20091999","article-title":"TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo","volume":"207","author":"Gottschalk","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2020.104236_b0425","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0430","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0435","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/eji.200738109","article-title":"Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg","volume":"38","author":"Horwitz","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0440","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104236_b0445","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2018.00233","article-title":"Engineered T regulatory type 1 cells for clinical application","volume":"9","author":"Gregori","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0450","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0455","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0460","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3466","article-title":"Immunometabolism of regulatory T cells","volume":"17","author":"Newton","year":"2016","journal-title":"Nat. Immunol."},{"issue":"6652","key":"10.1016\/j.cellimm.2020.104236_b0465","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0470","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10\u2013dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0475","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0480","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3\u2212 precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0485","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10\u2013producing anti-inflammatory T cells","volume":"8","author":"Awasthi","year":"2007","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20020394","article-title":"Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells","volume":"196","author":"Jonuleit","year":"2002","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0495","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/eji.200324656","article-title":"Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells","volume":"34","author":"Stassen","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0500","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","article-title":"Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific","volume":"164","author":"Thornton","year":"2000","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0505","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2004-10-3888","article-title":"CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation","volume":"105","author":"Karim","year":"2005","journal-title":"Blood"},{"issue":"7385","key":"10.1016\/j.cellimm.2020.104236_b0510","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10772","article-title":"Extrathymically generated regulatory T cells control mucosal TH2 inflammation","volume":"482","author":"Josefowicz","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0515","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1500703","article-title":"Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry","volume":"195","author":"Mason","year":"2015","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0520","doi-asserted-by":"crossref","first-page":"a007021","DOI":"10.1101\/cshperspect.a007021","article-title":"Treg cells, life history, and diversity","volume":"4","author":"Benoist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"44","key":"10.1016\/j.cellimm.2020.104236_b0525","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3<sup>+<\/sup>CD4<sup>+<\/sup> regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0530","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2010.03291.x","article-title":"Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype","volume":"10","author":"Dwyer","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0535","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.176.8.4622","article-title":"MHC class II expression identifies functionally distinct human regulatory T cells","volume":"176","author":"Baecher-Allan","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0540","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201243296","article-title":"CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner","volume":"43","author":"Afzali","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0545","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","article-title":"Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells","volume":"36","author":"Miyao","year":"2012","journal-title":"Immunity"},{"issue":"5999","key":"10.1016\/j.cellimm.2020.104236_b0550","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0555","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with De Novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.cellimm.2020.104236_b0565","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0570","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0575","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"issue":"7658","key":"10.1016\/j.cellimm.2020.104236_b0580","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0585","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellimm.2020.104236_b0590","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0595","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","article-title":"Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response","volume":"39","author":"Bailey-Bucktrout","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0600","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"50","key":"10.1016\/j.cellimm.2020.104236_b0605","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1073\/pnas.0704397104","article-title":"Allograft rejection mediated by memory T cells is resistant to regulation","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0610","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2009.03053.x","article-title":"Regulatory T cells overturned: the effectors fight back","volume":"126","author":"Walker","year":"2009","journal-title":"Immunology"},{"issue":"7581","key":"10.1016\/j.cellimm.2020.104236_b0615","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature16169","article-title":"Immune homeostasis enforced by co-localized effector and regulatory T cells","volume":"528","author":"Liu","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0620","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0625","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1158\/2326-6066.CIR-14-0161","article-title":"The immunological synapse","volume":"2","author":"Dustin","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"15","key":"10.1016\/j.cellimm.2020.104236_b0630","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1242\/jcs.186205","article-title":"The cytotoxic T lymphocyte immune synapse at a glance","volume":"129","author":"Dieckmann","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellimm.2020.104236_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6881-7_1","article-title":"The immune synapse: past, present, and future","volume":"1584","author":"Dustin","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0640","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20082902","article-title":"A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity","volume":"206","author":"Hsu","year":"2009","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0645","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.0902876","article-title":"The role of the LAT-PLC-gamma1 interaction in T regulatory cell function","volume":"184","author":"Chuck","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0650","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ni.3004","article-title":"Continuous requirement for the TCR in regulatory T cell function","volume":"15","author":"Levine","year":"2014","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0655","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.immuni.2014.10.012","article-title":"Continuous T cell receptor signals maintain a functional regulatory T cell pool","volume":"41","author":"Vahl","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104236_b0660","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fimmu.2016.00024","article-title":"Cell type-specific regulation of immunological synapse dynamics by B7 ligand recognition","volume":"7","author":"Brzostek","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0665","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2567.2000.00121.x","article-title":"CD28, CTLA-4 and their ligands: who does what and to whom?","volume":"101","author":"Sansom","year":"2000","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0670","doi-asserted-by":"crossref","first-page":"e6580","DOI":"10.1371\/journal.pone.0006580","article-title":"Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking","volume":"4","author":"Kim","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0675","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cyto.a.20659","article-title":"Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy","volume":"75","author":"Trzonkowski","year":"2009","journal-title":"Cytometry A"},{"key":"10.1016\/j.cellimm.2020.104236_b0680","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0685","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104236_b0690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-12-417027-8.00003-9","article-title":"Membrane protein dynamics and functional implications in mammalian cells","volume":"72","author":"Alenghat","year":"2013","journal-title":"Curr. Top. Membr."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0695","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.immuni.2010.09.006","article-title":"Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation","volume":"33","author":"Yokosuka","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0700","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"issue":"28","key":"10.1016\/j.cellimm.2020.104236_b0705","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1073\/pnas.0403342101","article-title":"Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease","volume":"101","author":"Paust","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1711.1999.00795.x","article-title":"The role of CTLA-4 in the regulation of T cell immune responses","volume":"77","author":"McCoy","year":"1999","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0715","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b0720","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"5588","key":"10.1016\/j.cellimm.2020.104236_b0725","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1126\/science.1073514","article-title":"Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase","volume":"297","author":"Munn","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0730","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.162.1.186","article-title":"CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha","volume":"162","author":"Liao","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b0735","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2004-07-2505","article-title":"CCR6 expression defines regulatory effector\/memory-like cells within the CD25(+)CD4+ T-cell subset","volume":"105","author":"Kleinewietfeld","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0740","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104236_b0745","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3389\/fimmu.2018.02374","article-title":"Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression","volume":"9","author":"Gianchecchi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0750","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0755","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI16015","article-title":"Costimulating aberrant T cell responses by B7\u2013H1 autoantibodies in rheumatoid arthritis","volume":"111","author":"Dong","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0760","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/eji.200635978","article-title":"Contribution of the PD-1 ligands\/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation","volume":"36","author":"Kuipers","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0765","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"issue":"2374","key":"10.1016\/j.cellimm.2020.104236_b0770","article-title":"Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression","volume":"9","author":"Gianchecchi","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0775","doi-asserted-by":"crossref","first-page":"e83139","DOI":"10.1371\/journal.pone.0083139","article-title":"Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells","volume":"8","author":"Dilek","year":"2013","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.cellimm.2020.104236_b0780","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b0785","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.4049\/jimmunol.162.8.4567","article-title":"TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells","volume":"162","author":"Geissmann","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0790","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000067596","article-title":"The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells","volume":"129","author":"Levings","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0795","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"issue":"7169","key":"10.1016\/j.cellimm.2020.104236_b0800","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104236_b0805","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.cellimm.2020.104236_b0810","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1286-4579(99)00256-7","article-title":"TGF-beta1 regulation of dendritic cells","volume":"1","author":"Strobl","year":"1999","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0815","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0820","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0825","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","article-title":"Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells","volume":"104","author":"Grossman","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0830","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.cdd.4402220","article-title":"Involvement of cellular death in TRAIL\/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells","volume":"14","author":"Ren","year":"2007","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0835","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0840","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0845","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0850","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","article-title":"A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells","volume":"111","author":"Zarek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104236_b0855","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2016.00315","article-title":"Cyclic AMP represents a crucial component of treg cell-mediated immune regulation","volume":"7","author":"Klein","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0860","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.01.002","article-title":"Regulatory T cell migration during an immune response","volume":"33","author":"Ding","year":"2012","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b0865","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0870","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fimmu.2015.00438","article-title":"Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation","volume":"6","author":"Safinia","year":"2015","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0875","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b0880","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1523\/JNEUROSCI.1815-18.2019","article-title":"Regulatory T cells and their derived cytokine, interleukin-35, reduce pain in experimental autoimmune encephalomyelitis","volume":"39","author":"Duffy","year":"2019","journal-title":"J. Neurosci."},{"issue":"39","key":"10.1016\/j.cellimm.2020.104236_b0885","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1073\/pnas.1705599114","article-title":"Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development","volume":"114","author":"Yu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0890","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ajt.12647","article-title":"Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning","volume":"14","author":"Juvet","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0895","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0900","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0905","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cellimm.2020.104236_b0910","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104236_b0915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0920","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.coi.2011.06.006","article-title":"Regulatory T cells in stem cell transplantation: strategies and first clinical experiences","volume":"23","author":"Edinger","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0925","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcyt.2014.11.005","article-title":"Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease","volume":"17","author":"Theil","year":"2015","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0930","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2047-1440-1-11","article-title":"The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cells","volume":"1","author":"Geissler","year":"2012","journal-title":"Transplant. Res."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b0935","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b0940","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cellimm.2020.104236_b0945","doi-asserted-by":"crossref","unstructured":"J.A. Bluestone, et al., Type 1 diabetes immunotherapy using polyclonal regulatory T cells, Sci. Transl. Med. 7(315) (2015) 315ra189.","DOI":"10.1126\/scitranslmed.aad4134"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b0950","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1053\/j.gastro.2019.01.025","article-title":"Correction of defective T-regulatory cells from patients with Crohn's disease by ex vivo ligation of retinoic acid receptor-\u03b1","volume":"156","author":"Goldberg","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2020.104236_b0955","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3389\/fimmu.2015.00593","article-title":"Clinical outlook for type-1 and FOXP3(+) T regulatory cell-based therapy","volume":"6","author":"Gregori","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b0960","unstructured":"A. Madeleine, Caladrius refuses to give up on Tregs for diabetes, 2019. Available from: https:\/\/www.evaluate.com\/vantage\/articles\/interviews\/caladrius-refuses-give-tregs-diabetes."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0965","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOT.0b013e328355a992","article-title":"Regulatory T-cell therapy for transplantation: how many cells do we need?","volume":"17","author":"Tang","year":"2012","journal-title":"Curr. Opin. Organ. Transplant."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b0970","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.18632\/oncotarget.6927","article-title":"Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation","volume":"7","author":"Safinia","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b0975","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b0980","doi-asserted-by":"crossref","first-page":"e2233","DOI":"10.1371\/journal.pone.0002233","article-title":"Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy","volume":"3","author":"Peters","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b0985","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b0990","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b0995","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1000","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1010","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.174.10.5926","article-title":"Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help","volume":"174","author":"Fuller","year":"2005","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b1015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20030725","article-title":"IL-7 promotes the transition of CD4 effectors to persistent memory cells","volume":"198","author":"Li","year":"2003","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1600-6143.2003.00293.x","article-title":"CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential","volume":"4","author":"Fu","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1030","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI23963","article-title":"A peripheral circulating compartment of natural naive CD4 Tregs","volume":"115","author":"Valmori","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.cellimm.2020.104236_b1035","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/gutjnl-2014-306919","article-title":"Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease","volume":"65","author":"Canavan","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20041033","article-title":"Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node","volume":"202","author":"Samy","year":"2005","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b1050","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.174.11.6993","article-title":"Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells","volume":"174","author":"Ochando","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b1060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2004-01-0151","article-title":"In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures","volume":"104","author":"Godfrey","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1065","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b1070","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b1075","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.4049\/jimmunol.171.12.6431","article-title":"IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression","volume":"171","author":"Koenen","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b1080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.cji.0000203080.43235.9e","article-title":"Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease","volume":"29","author":"Karakhanova","year":"2006","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b1090","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1095","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A Phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1100","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/s41598-017-03456-8","article-title":"TGF-beta\/atRA-induced tregs express a selected set of microRNAs involved in the repression of transcripts related to Th17 differentiation","volume":"7","author":"Schiavinato","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b1105","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3324\/haematol.2012.074088","article-title":"Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations","volume":"98","author":"Scotta","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cellimm.2020.104236_b1110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtm.2018.01.006","article-title":"A Rapamycin-based GMP-compatible process for the isolation and expansion of regulatory T cells for clinical trials","volume":"8","author":"Fraser","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not Rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b1120","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.180.9.5794","article-title":"Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin","volume":"180","author":"Basu","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12967-017-1133-8","article-title":"Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression","volume":"15","author":"Mfarrej","year":"2017","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.intimp.2009.01.032","article-title":"Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases","volume":"9","author":"Brun","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b1140","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3324\/haematol.2010.025825","article-title":"Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy","volume":"95","author":"Rosa","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.cellimm.2020.104236_b1145","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/intimm\/4.12.1389","article-title":"Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures","volume":"4","author":"Bejarano","year":"1992","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1389201019666180418095526","article-title":"CAR T-cell therapy: a new era in cancer immunotherapy","volume":"19","author":"Miliotou","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.cellimm.2020.104236_b1155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biomedicines4020009","article-title":"Genetic modification of T cells","volume":"4","author":"Morgan","year":"2016","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1160","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1165","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood-2004-09-3579","article-title":"Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes","volume":"105","author":"Mekala","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104236_b1170","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0470-3","article-title":"Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells","author":"Wu","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b1175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2017.01.001","article-title":"Generation of human islet-specific regulatory T cells by TCR gene transfer","volume":"79","author":"Hull","year":"2017","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1180","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2014-04-566786","article-title":"Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses","volume":"125","author":"Kim","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1185","doi-asserted-by":"crossref","first-page":"e11726","DOI":"10.1371\/journal.pone.0011726","article-title":"Human antigen-specific regulatory T cells generated by T cell receptor gene transfer","volume":"5","author":"Brusko","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1190","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.drudis.2018.02.012","article-title":"Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts","volume":"23","author":"Zheng","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b1195","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1634\/theoncologist.2019-0233","article-title":"The European medicines agency review of Kymriah (Tisagenlecleucel) for the treatment of acute lymphoblastic leukemia and diffuse large B-cell lymphoma","volume":"25","author":"Ali","year":"2020","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"6295","key":"10.1016\/j.cellimm.2020.104236_b1205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cellimm.2020.104236_b1210","doi-asserted-by":"crossref","first-page":"e57838","DOI":"10.1371\/journal.pone.0057838","article-title":"Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials","volume":"8","author":"Jena","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1215","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1053\/j.gastro.2008.02.060","article-title":"Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice","volume":"134","author":"Elinav","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1220","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2009.01.049","article-title":"Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor","volume":"136","author":"Elinav","year":"2009","journal-title":"Gastroenterology"},{"issue":"33","key":"10.1016\/j.cellimm.2020.104236_b1225","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1073\/pnas.0505445102","article-title":"IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes","volume":"102","author":"Mekala","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.cellimm.2020.104236_b1230","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1073\/pnas.162359999","article-title":"Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors","volume":"99","author":"Riley","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA Class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1240","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/ajt.15787","article-title":"Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients","volume":"20","author":"Sicard","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"6059","key":"10.1016\/j.cellimm.2020.104236_b1245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/320232a0","article-title":"Transfer of specificity by murine alpha and beta T-cell receptor genes","volume":"320","author":"Dembi\u0107","year":"1986","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b1250","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1172\/JCI33185","article-title":"Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice","volume":"118","author":"Tsang","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"45","key":"10.1016\/j.cellimm.2020.104236_b1255","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.0907396106","article-title":"Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis","volume":"106","author":"Wright","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2020.104236_b1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2018.05.003","article-title":"Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells","author":"Kim","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2020.104236_b1265","unstructured":"Pohl et al., Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression, (not in Pubmed yet)."},{"key":"10.1016\/j.cellimm.2020.104236_b1270","doi-asserted-by":"crossref","unstructured":"B. Howie, et al., High-throughput pairing of T cell receptor \u03b1 and \u03b2 sequences, Sci. Transl. Med. 7(301) (2015) 301ra131.","DOI":"10.1126\/scitranslmed.aac5624"},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1275","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nbt.2938","article-title":"Linking T-cell receptor sequence to functional phenotype at the single-cell level","volume":"32","author":"Han","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"7661","key":"10.1016\/j.cellimm.2020.104236_b1280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"Glanville","year":"2017","journal-title":"Nature"},{"issue":"7661","key":"10.1016\/j.cellimm.2020.104236_b1285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature22383","article-title":"Quantifiable predictive features define epitope-specific T cell receptor repertoires","volume":"547","author":"Dash","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cellimm.2020.104236_b1290","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1158\/0008-5472.CAN-06-3986","article-title":"Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond","volume":"67","author":"Cohen","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1295","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-05-023069","article-title":"Facilitating matched pairing and expression of TCR chains introduced into human T cells","volume":"109","author":"Kuball","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104236_b1300","first-page":"111","article-title":"CD28 co-stimulation in T-cell homeostasis: a recent perspective","volume":"4","author":"Beyersdorf","year":"2015","journal-title":"Immunotargets Ther"},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1305","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.1302074","article-title":"TCRs genetically linked to CD28 and CD3\u03b5 do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity","volume":"193","author":"Govers","year":"2014","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1310","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/cmi.2015.44","article-title":"Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance","volume":"12","author":"Zeng","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b1315","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1320","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ymthe.2017.06.029","article-title":"IL-10-engineered human CD4(+) Tr1 cells eliminate myeloid leukemia in an HLA Class I-dependent mechanism","volume":"25","author":"Locafaro","year":"2017","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104236_b1325","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J. Clin. Immunol."},{"issue":"6411","key":"10.1016\/j.cellimm.2020.104236_b1330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.aau2688","article-title":"Treg cells-the next frontier of cell therapy","volume":"362","author":"Bluestone","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b1335","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood-2016-07-727834","article-title":"FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII","volume":"129","author":"Yoon","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1340","first-page":"347","article-title":"Epitope spreading: a mechanism for progression of autoimmune disease","volume":"48","author":"Tuohy","year":"2000","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104236_b1350","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104236_b1355","doi-asserted-by":"crossref","unstructured":"L. Passerini, et al., CD4(+) T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer, Sci. Transl. Med. 5(215) (2013) 215ra174.","DOI":"10.1126\/scitranslmed.3007320"},{"issue":"6","key":"10.1016\/j.cellimm.2020.104236_b1360","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.39091","article-title":"Helios enhances treg cell function in cooperation with FoxP3","volume":"67","author":"Takatori","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"7455","key":"10.1016\/j.cellimm.2020.104236_b1365","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature12199","article-title":"BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis","volume":"498","author":"Roychoudhuri","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104236_b1370","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"304","key":"10.1016\/j.cellimm.2020.104236_b1375","doi-asserted-by":"crossref","first-page":"p. 304ps18","DOI":"10.1126\/scitranslmed.aaa7721","article-title":"Hurdles in therapy with regulatory T cells","volume":"7","author":"Trzonkowski","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.cellimm.2020.104236_b1380","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcyt.2014.05.016","article-title":"Purification of regulatory T cells with the use of a fully enclosed high-speed microfluidic system","volume":"16","author":"Hulspas","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cellimm.2020.104236_b1385","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3389\/fimmu.2017.01844","article-title":"Minimum information about T regulatory cells: a step toward reproducibility and standardization","volume":"8","author":"Fuchs","year":"2017","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104236_b1390","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b1395","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1074-7613(02)00279-0","article-title":"Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals","volume":"16","author":"Green","year":"2002","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104236_b1400","doi-asserted-by":"crossref","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.cellimm.2020.104236_b1405","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","article-title":"Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study","volume":"5","author":"Thonhoff","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104236_b1410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCRESAHA.114.305495","article-title":"Allogeneic cell therapy: a new paradigm in therapeutics","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104236_b1415","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/cei.12887","article-title":"T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells","volume":"187","author":"Theil","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"2250","key":"10.1016\/j.cellimm.2020.104236_b1420","article-title":"Engineered T cell therapy for cancer in the clinic","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:05:25Z","timestamp":1757804725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920303968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":284,"alternative-id":["S0008874920303968"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104236","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104236"}}